⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL127294 | 0.96 | — | — | |
| SCHEMBL27571033 | 0.92 | — | — | |
| Ammonia Solution, Strong SCHEMBL27554092 | 0.92 | — | — | |
| SCHEMBL27388917 | 0.92 | — | — | |
| Ethylamine SCHEMBL868902 | 0.79 | — | — | |
| Sulfuric Acid SCHEMBL15809904 | 0.73 | — | — | |
| SCHEMBL15385095 | 0.72 | — | — | |
| Methane SCHEMBL5575970 | 0.70 | CA5A (0.42) | — | |
| Sulfuric Acid SCHEMBL28073997 | 0.70 | — | — | |
| SCHEMBL14728244 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118368984-A | Organic sulfur compounds as plant biostimulants | 农作物健康愿景有限公司 | 2024-07-19 | — | — | CN | disclosed |
| WO-2018136825-A1 | HIGHLY MULTIPLEXED AND MASS SPECTROMETRY BASED METHODS TO MEASURING 72 HUMAN PROTEINS | CEDARS-SINAI MEDICAL CENTER (US) | 2018-07-26 | — | — | WO | disclosed |
| US-20180052105-A1 | SULFANE SULFUR-SELECTIVE FLUORESCENT PROBE | THE UNIVERSITY OF TOKYO (JP) | 2018-02-22 | — | — | US | disclosed |
| US-8791292-B2 | Dimethyl disulphide derived at least partially from renewable materials | ARKEMA FRANCE (FR) | 2014-07-29 | — | — | US | disclosed |
| WO-2011103049-A2 | METHOD FOR SCREENING RECEPTORS/LIGANDS INTERACTIONS | IMMUNE DISEASE INSTITUTE, INC. (US) | 2011-08-25 | — | — | WO | disclosed |
| US-20110172138-A1 | Dimethyl Disulphide Derived at least partially from Renewable Materials | ARKEMA FRANCE (FR) | 2011-07-14 | — | — | US | disclosed |
| US-7785825-B2 | Compositions and methods for dehydration and cyclization of peptides, synthetic compounds, and lantibiotics | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2010-08-31 | — | — | US | disclosed |
| CN-100522955-C | Cytotoxic agents containing novel potent taxanes and their therapeutic use | IMMUNOGEN INC (US) | 2009-08-05 | — | — | CN | disclosed |
| CN-1684948-A | Cytotoxic agents containing novel potent taxanes and their therapeutic use | IMMUNOGEN INC (US) | 2005-10-19 | — | — | CN | disclosed |
| US-20050164339-A1 | Compositions and methods for dehydration and cyclization of peptides, synthetic compounds, and lantibiotics | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-07-28 | — | — | US | disclosed |
| US-6066760-A | Process for the preparation of alkane sulfonic acid and alkane sulfonyl chloride | ELF ATOCHEM NORTH AMERICA, INC. (US) | 2000-05-23 | — | — | US | disclosed |
| US-5910427-A | PROTEIN DERIVATIVES FORMED BY REPLACEMENT, SUBSTITUTION, OR CHEMICAL MODIFICATION OF AMINO ACIDS 57 AND/OR 60 HAVING INCREASED ACTIVITY; FOR IMMUNOSUPPRESSIVES/ALLERGY TREATMENTS | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (US) | 1999-06-08 | — | — | US | disclosed |
| EP-0675106-B1 | A process for the preparation of alkane sulfonic acid and alkane sulfonyl chloride | ATOCHEM NORTH AMERICA ELF (US) | 1998-11-18 | — | — | EP | disclosed |
| EP-0833913-A1 | ANTIGEN NON-SPECIFIC GLYCOSYLATION INHIBITING FACTOR DERIVATIVES | KIRIN BEER KABUSHIKI KAISHA (JP) | 1998-04-08 | — | — | EP | disclosed |
| WO-1997000959-A1 | ANTIGEN NON-SPECIFIC GLYCOSYLATION INHIBITING FACTOR DERIVATIVES | KIRIN BEER KABUSHIKI KAISHA (JP) | 1997-01-09 | — | — | WO | disclosed |
| EP-0675106-A1 | A process for the preparation of alkane sulfonic acid and alkane sulfonyl chloride | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1995-10-04 | — | — | EP | disclosed |